Comments
Loading...
Aerovate Therapeutics (AVTE) Forecast
NewsEarningsAerovate Therapeutics (AVTE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAerovate Therapeutics (NASDAQ:AVTE) Stock Quotes, Forecast and News Summary
Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aerovate Therapeutics (AVTE) stock?
You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.
Who are Aerovate Therapeutics (AVTE) competitors?
Other companies in Aerovate Therapeutics’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the forecast, or price target, for Aerovate Therapeutics (AVTE) stock?
Aerovate Therapeutics has a consensus price target of $11.75.
What is the current price for Aerovate Therapeutics (AVTE)?
The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.62 last updated November 21, 2024 at 2:35 PM EST.
Does Aerovate Therapeutics (AVTE) pay a dividend?
There are no upcoming dividends for Aerovate Therapeutics.
When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?
Aerovate Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Aerovate Therapeutics (AVTE) going to split?
There is no upcoming split for Aerovate Therapeutics.
What sector and industry does Aerovate Therapeutics (AVTE) operate in?
Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.